Global Coalition for Adaptive Research, Kazia, and Kintara Announce Commencement of Kazia’s Paxalisib and Kintara’s VAL-083 in GBM AGILE Trial
LOS ANGELES--(BUSINESS WIRE)--GCAR, Kazia, and Kintara Announce Commencement of Kazia’s paxalisib and Kintara’s VAL-083 in GBM AGILE
